Please login to the form below

Not currently logged in
Email:
Password:

Dr Thomas Lynch Jnr takes up new role at Bristol-Myers Squibb

Will focus on leading the firm's research and development programme

Dr Thomas Lynch JnrBristol-Myers Squibb (BMS) has appointed Dr Lynch as executive vp and chief scientific officer, a role that will see him focus on leading the firm’s research and development programme.

He previously served on the firm's board of directors and succeeds Dr Francis Cuss who will retire from the company.

Dr Lynch said: “I have seen first-hand Bristol-Myers Squibb’s commitment to making a meaningful difference in the lives of patients, and I am honoured to lead the company’s R&D programme.

“I am confident that our team will continue to discover and develop innovative medicines that address serious diseases in areas of significant unmet medical need.”

Dr Lynch has more than 30 years medical, management and leadership experience and joined BMS in 2013 from the Yale Cancer Center.

Giovanni Caforio, chief executive officer at Bristol-Myers Squibb, added: “Tom brings deep industry knowledge and a sophisticated understanding of the Bristol-Myers Squibb research and development programme from his experience as a member of our Board.

“As we transition to our next phase of growth, we are confident Tom is the right person to lead our dynamic R&D organisation as we focus on accelerating the development of our immuno-oncology medicines.”

28th March 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics